BIOMAT Database Logo BIOMAT Database Logo

Circulating adhesion molecules during kidney allograft rejection. 1995

G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
Nephrology Services, University Hospital Marqués de Valdecilla, Santander, Spain.

Adhesion molecules appear on leukocytes and endothelial cells mediating the localization and migration of leukocytes to sites of inflammation. Rejecting kidney grafts have shown an increased expression of these molecules. Recent reports have detected in serum soluble forms of adhesion molecules that could play a role in regulating inflammation. We have measured by ELISA the circulating serum levels of ICAM-1, VCAM-1 and E-selectin in: 23 controls, 33 chronic renal failure patients (CRF), 20 hemodialysis patients (HD), 17 samples from 6 patients with stable kidney graft function (STx), 25 samples from 8 patients with steroid-responsive rejection proven by biopsy, and 28 samples from 9 patients with steroid-resistant rejection and good response to OKT3. There was not a rise in cICAM-1 or cE-selectin levels during rejection compared with the steady phase before and after rejection. In the case of cVCAM-1, only the OKT3 group showed increased rejection levels (P < 0.05) that were maintained after rejection. For ICAM-1, CRF and HD groups had higher levels than the remaining groups. cVCAM-1 levels were elevated in all groups when compared with control, furthermore, OKT3 and HD groups had higher levels than the STx, CRF, or steroid-responsive groups. For cE-selectin, we only found differences between the CRF and both rejection groups. Serum creatinine correlated significantly with c-ICAM-1 and cVCAM-1 R = 0.30 and R = 0.22), but not with cE-selectin. We conclude that soluble adhesion molecules levels are not valuable markers for rejection. Patients with chronic renal failure have increased levels of adhesion molecules, which could reflect an impaired elimination.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D015815 Cell Adhesion Molecules Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis. Cell Adhesion Molecule,Intercellular Adhesion Molecule,Intercellular Adhesion Molecules,Leukocyte Adhesion Molecule,Leukocyte Adhesion Molecules,Saccharide-Mediated Cell Adhesion Molecules,Saccharide Mediated Cell Adhesion Molecules,Adhesion Molecule, Cell,Adhesion Molecule, Intercellular,Adhesion Molecule, Leukocyte,Adhesion Molecules, Cell,Adhesion Molecules, Intercellular,Adhesion Molecules, Leukocyte,Molecule, Cell Adhesion,Molecule, Intercellular Adhesion,Molecule, Leukocyte Adhesion,Molecules, Cell Adhesion,Molecules, Intercellular Adhesion,Molecules, Leukocyte Adhesion
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D018799 Intercellular Adhesion Molecule-1 A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. Antigens, CD54,CD54 Antigens,ICAM-1,CD54 Antigen,Antigen, CD54,Intercellular Adhesion Molecule 1
D019010 Vascular Cell Adhesion Molecule-1 Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. (From Pigott & Power, The Adhesion Molecule FactsBook, 1993, p154) Antigens, CD106,CD106 Antigens,VCAM-1,CD106 Antigen,INCAM-110,Inducible Cell Adhesion Molecule 110,Vascular Cell Adhesion Molecule,Antigen, CD106,Vascular Cell Adhesion Molecule 1

Related Publications

G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
Circulating adhesion molecules during kidney allograft reperfusion.
November 2006, Transplant immunology,
G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
Circulating adhesion molecules and purine nucleotides during kidney allograft reperfusion.
January 2009, Transplantation proceedings,
G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
Different time course of circulating adhesion molecules and hyaluran during hepatic allograft rejection.
February 2000, Transplantation,
G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
Cell adhesion molecules: from kidney morphogenesis to allograft rejection.
October 1994, Pediatric nephrology (Berlin, Germany),
G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
The role played by adhesion molecules during allograft rejection.
June 1994, Transplant immunology,
G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
Lymphocyte adhesion molecules in renal allograft rejection.
December 1996, Transplantation proceedings,
G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
Differential expression of adhesion molecules during rat small bowel allograft rejection.
November 1995, Transplantation,
G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
Role of adhesion molecules in chronic allograft rejection.
January 1999, Archivum immunologiae et therapiae experimentalis,
G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
Expression of cell adhesion molecules in human cardiac allograft rejection.
January 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
G Alcalde, and J Merino, and S Sanz, and J A Zubimendi, and J C Ruiz, and J Torrijos, and A L de Francisco, and J G Cotorruelo, and M López-Hoyos, and M J Novo
Adhesion molecules and the mechanisms of kidney rejection.
June 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!